Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-22-067761)

Filing Details

Accession Number:: 0001104659-22-067761
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-02 20:01:53
Reporting Period:: 2022-05-31

Accepted Time:: 2022-06-02 20:01:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425205	Iovance Biotherapeutics Inc.	IOVA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221449	Michael Weiser	C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-31	2,187	$6.79	104,819	No	4	P	Direct
Common Stock	Acquisiton	2022-05-31	7,813	$6.80	112,632	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	28,484	Indirect	By Actin Capital Partners, LLC

Footnotes

The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.